Nureca IPO GMP History
Nureca IPO has been listed on February 25, 2021 at a listing price of ₹615, against the issue price of ₹400 — a gain of ₹215 (+53.75%). The day-wise GMP trend below shows how grey market sentiment evolved from subscription to listing.
Nureca IPO raised ₹100 Cr. through its IPO at a price band of ₹396 to ₹400 per share, with a lot size of 35 shares. The IPO was open for subscription from 15 Feb 2021 to 17 Feb 2021.
GMP trend
Grey market premium sampled three times a day (11 AM, 5 PM, 10 PM). Last updated 10 Nov, 7:18 AM IST.
Day-wise GMP
The last reading of each day, newest first. Arrows compare with the previous day.
| Date | GMP | ↑↓ | % | Kostak | Sub. Sauda |
|---|---|---|---|---|---|
| No GMP history available yet. | |||||
Nureca IPO dates
Key dates from opening to listing. Today is 11 November.
- Open 15 Feb 2021
- Close 17 Feb 2021
- Allotment 23 Feb 2021
- Refund/credit 24 Feb 2021
- Listing 25 Feb 2021
Nureca IPO actual listing price
How the grey market's final call compared with the listing-day open.
| Issue price | ₹400 |
|---|---|
| Listing gain / loss | +₹215 per share |
| Listing date | 25 Feb, 2021 |
| Actual listing price | ₹615 (+53.75%) |
Is Nureca IPO GMP reliable?
Grey market premium for Nureca IPO should be interpreted with caution. The GMP is an unregulated, unofficial market not governed by SEBI. Here's how to read the current signal:
- 01Subscription rate matters: A high GMP paired with strong subscription — especially QIB (Qualified Institutional Buyer) oversubscription — is a more reliable bullish signal than GMP alone. Read our in-depth analysis: GMP vs Subscription Data — Which Predicts Listing Gains Better?
- 02Timing matters: GMP in the first 1–2 days of subscription is less reliable. GMP on the final subscription day and the day before listing tends to be the most accurate predictor.
- 03Grey market is thin: For smaller IPOs, even a handful of large orders can swing the GMP significantly. Treat low-volume GMP signals with extra caution.
- 04Cross-check before acting: Review the Nureca IPO full review for a fundamentals-based assessment before making any grey market trades.
Nureca IPO Kostak rate explained
Two ways the grey market trades an IPO application before listing.
The Kostak rate for Nureca IPO was not available during the subscription period. Kostak is the fixed amount a grey market buyer pays for an IPO application regardless of allotment outcome.
The Subject to Sauda price was not available for this IPO. Subject to Sauda only applies if allotment is confirmed — the buyer pays a premium on top of the issue price per lot allotted.
Grey market trading is unofficial and unregulated by SEBI. Proceed with full awareness of the associated risks.
About Nureca IPO
Nureca Limited was incorporated on 2 November 2016 and started operations in Fiscal 2017. It is a B2C company that sells home healthcare and wellness products.
Its range covers chronic device products, orthopaedic products, mother and child products, nutrition supplements and lifestyle products. These help customers keep track of chronic ailments at home.
It is a digital first company. Products are sold through e-commerce players, distributors and retailers, and through its own website drtrust.in. Dr Trust is its main brand.
The IPO was Rs 100 crore and was entirely fresh issue. Rs 75.00 crore of the proceeds was planned for incremental working capital.
Frequently asked
What is the GMP of Nureca IPO?
The current Grey Market Premium (GMP) of Nureca IPO is not yet started or active in the market.
What is the Kostak Price of Nureca IPO?
Kostak rate is the profit made by selling an IPO application before allotment. The current Kostak rate for Nureca IPO is not available.
What is the Subject to Sauda Price of Nureca IPO?
Subject to Sauda is the premium amount decided if the allotment is confirmed. The current Subject to Sauda rate is not available.
What was the actual listing price of Nureca IPO?
Nureca IPO listed on February 25, 2021 at ₹615, against the issue price of ₹400 — a gain of +53.75%.
How did the GMP of Nureca IPO trend before listing?
The GMP of Nureca IPO was stable in its final days before listing. View the day-wise table above for the complete GMP history.
Explore Nureca IPO further
The grey market is one signal. Read it alongside the demand, the reviews and the filings before you decide.
It has listed — go back to the fundamentals.
Category-wise demand from QIB, NII and retail investors, updated through the day.
What brokers and analysts are saying about this issue, in one place.
Check with your PAN whether shares were credited to your demat account.
The grey market called it. Now check the fundamentals.
IPO Guru tracks GMP, subscription and allotment for every Mainboard and SME issue. Read the grey market alongside the subscription book and the offer document before you apply.
Not investment advice. Grey market premium is an unofficial, unregulated indicator and is not a forecast.